Sickle Cell Mutation Screening Prenatal Test
At DNA Labs UAE, we offer the Sickle Cell Mutation Screening Prenatal Test for individuals who want to determine if their fetus carries the genetic mutation for sickle cell disease (SCD). SCD is an inherited blood disorder that can cause various health problems. The screening test is usually recommended for couples who are at a higher risk of having a child with SCD, such as those with a family history of the disease or individuals from certain ethnic backgrounds.
Test Details
The Sickle Cell Mutation Screening Prenatal Test is a genetics test that involves analyzing a blood sample to identify the presence of the sickle cell mutation. The test is typically performed on the mother during the first trimester of pregnancy. The sample condition required for this test includes amniotic fluid, chorionic villi, or cord blood. The test is conducted using the End Point PCR method.
Test Components
- Sterile container
- Sterile Normal Saline Container
- EDTA Vacutainer (2ml)
Price
The cost of the Sickle Cell Mutation Screening Prenatal Test is 1200.0 AED.
Report Delivery
You can expect to receive your test results within 3-4 days after the sample is received.
Doctor
This test can be ordered by a General Physician.
Test Department
This test falls under the Genetics department.
Pre Test Information
A doctor’s prescription is required for the Sickle Cell Mutation Screening Prenatal Test. However, please note that the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Symptoms and Diagnosis
Sickle cell mutation screening is performed to determine if a fetus carries the genetic mutation for sickle cell disease. Symptoms of SCD can vary and may include pain, anemia, infections, and organ damage. Diagnostic testing, such as chorionic villus sampling (CVS) or amniocentesis, may be recommended if the screening test results are positive. These procedures involve obtaining a sample of fetal cells for further genetic testing.
Who Should Consider the Test?
The Sickle Cell Mutation Screening Prenatal Test is usually offered to couples who are at a higher risk of having a child with SCD. This includes individuals with a family history of the disease or those from certain ethnic backgrounds, including African, Mediterranean, Middle Eastern, and Indian.
Importance of the Test
Knowing whether a fetus carries the sickle cell mutation can help parents make informed decisions about their pregnancy and plan for the future. Early intervention and management of the disease can be initiated if the child is diagnosed with SCD.
Should You Undergo the Test?
The decision to undergo the Sickle Cell Mutation Screening Prenatal Test is a personal choice. It is recommended to discuss this test with your healthcare provider, who can provide guidance based on your individual circumstances and risk factors.
| Test Name | Sickle Cell Mutation Screening Prenatal Test |
|---|---|
| Components | Sterile container / Sterile Normal Saline Container / EDTA Vacutainer (2ml) |
| Price | 1200.0 AED |
| Sample Condition | Amniotic fluid \/ Chorionic villi \/ Cord blood |
| Report Delivery | 3-4 days |
| Method | End Point PCR |
| Test type | Genetics |
| Doctor | General Physician |
| Test Department: | |
| Pre Test Information | Sickle Cell Mutation Screening Prenatal] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
| Test Details |
Sickle cell mutation screening is a prenatal test that is performed to determine if a fetus carries the genetic mutation for sickle cell disease (SCD). SCD is an inherited blood disorder that affects the red blood cells and can cause various health problems. The screening test is usually offered to couples who are at a higher risk of having a child with SCD, such as those with a family history of the disease or individuals from certain ethnic backgrounds, including African, Mediterranean, Middle Eastern, and Indian. The screening process involves a blood test, which is typically performed on the mother during the first trimester of pregnancy. The blood sample is analyzed to identify the presence of the sickle cell mutation. If the screening test results show that the fetus does carry the sickle cell mutation, further diagnostic testing may be recommended, such as chorionic villus sampling (CVS) or amniocentesis, to confirm the diagnosis. These procedures involve obtaining a sample of fetal cells for genetic testing. Knowing whether a fetus carries the sickle cell mutation can help parents make informed decisions about their pregnancy and plan for the future. It allows for early intervention and management of the disease if the child is diagnosed with SCD. It is important to note that sickle cell mutation screening is an optional test and is not routinely offered to all pregnant women. The decision to undergo screening is a personal choice and should be discussed with a healthcare provider, who can provide guidance based on individual circumstances and risk factors. |
